How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Whether you see it as the “latest” health craze, have considered taking it yourself, or, have been relying on it for some time now, you may have asked: Can someone take too much CBD? Here, we find out.
The Minister for Health continues to tackle the issue of access to medical cannabis, unemployment and sustainable energy via the idea of peat bogs as medical cannabis farms.
The National Institute for Health and Care Excellence (NICE) said they need more research into CBD medicines before the NHS can prescribe them in general.
CBD oil may help alleviate sleeping problems experienced as research reveals over 52% of Brits cite temperature as the main factor keeping them from getting enough sleep.
Research reveals Londoners are the most anxious and have the worst work-life balance in the UK and many would choose to use CBD oil rather than seeing their GP.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.
European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.
